庞国福,黎有富,李清,陈平峰,李解方,曹友汉,匡小根.腹腔引流导管行肾微造瘘在治疗上尿路梗阻并感染性休克中的应用.[J].中南医学科学杂志.,2014,42(5):479-481.
腹腔引流导管行肾微造瘘在治疗上尿路梗阻并感染性休克中的应用
The Application of Abdomen Drainage Catheter in the Mini-percutaneousNephroscopy for Upper Urinary Obstruction Combined with Septic Shock
投稿时间:2014-05-08  
DOI:
中文关键词:  肾微造瘘术(mPCN)  上尿路梗阻  肾积脓
英文关键词:mini-percutaneous nephroscopy  upper urinary tract obstruction  pyonephrosis
基金项目:
作者单位
庞国福,黎有富,李清,陈平峰,李解方,曹友汉,匡小根 南华大学附属第一医院泌尿外科,湖南 衡阳 421001 
摘要点击次数: 820
全文下载次数: 1228
中文摘要:
      目的介绍腹腔引流导管进行经皮肾穿刺微造瘘术(mPCN)在治疗上尿路梗阻并感染性休克中的应用。方法24例上尿路梗阻的患者均成功应用腹腔引流导管行经皮肾穿刺微造瘘术(mPCN)引流肾内脓液后,再根据患者身体的一般情况、有无继发感染、肾功能状态等进一步决定治疗方案。结果24例患者一般情况好转,感染及休克症状得到有效控制,肾功能好转,无明显并发症,24例均通过后期手术解除上尿路梗阻。结论
英文摘要:
      ObjectiveTo explore the application of abdomen drainage catheter in mini-percutaneous nephroscopy (mPCN) for acute upper tract obstruction combined with in septic shock.Methods24 cases were underwent mPCN through abdomen drainage catheter to drain the urine successfully,then according to renal function,with or without secondary infection,and the patients’ general condition to decide the further treatment.ResultsAfter mPCN,all the patients made remarkable improvement in their general condition with infection and septic shock rectified and renal function improved.Upper tract obstruction was relieved by secondary surgery in all cases,and there was no significant complications.ConclusionUsing abdomen catheter to conduct mPCN could be safe and effective in the treatment of upper tract obstruction combined with septic shock because of little injury,no obvious complications and rapid recovery.It is worth spreading.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=D5363C1B886C98C9003E26EE1954907CEF52B1AC461640D69A999E1B4F4F53454B8F5D0368629CE17A26D10BCC840DA515ABCD1F8ECEAD1FC619567BA5D7D9586C1E66E1992743F37C758B6EF711DB04B2A044F1A032979118029A4FB92F80BD4FF9865FC57BD8F727BAF37C4C76DCD846F5C5CF651F9A08226F62407EA8DA9051093756955D7A7E2D52B3F10B7742CD&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=9EAD63ADE6B277ED&aid=89B272DCE8EE7A02ABA726214EA321D7&vid=&iid=94C357A881DFC066&sid=A33A8FD1432A4C3E&eid=283B38DAD0D068F3&fileno=20140515&flag=1&is_more=0">